These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8785580)

  • 1. [What glycemic control can be achieved in young diabetics and what is the frequency of subclinical complications? A 4-year follow-up study].
    Dorchy H; Roggemans MP; Willems D
    Arch Pediatr; 1996 Mar; 3(3):294-6. PubMed ID: 8785580
    [No Abstract]   [Full Text] [Related]  

  • 2. [A combination of glycosylated hemoglobin and fasting blood glucose testing is necessary for the management of diabetics].
    Nunoi K
    Fukuoka Igaku Zasshi; 1984 May; 75(5):283-90. PubMed ID: 6489909
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetes: almost half the patient are inadequately adjusted - an action program offers a risk checkup].
    Pflege Z; 2011 Jun; 64(6):378. PubMed ID: 21735641
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term results of a diabetes education program. Effects on the metabolic control and clinical outcome of complications].
    Figuerola D; Reynals E; Micaló T; Levy I; Gomis R
    Med Clin (Barc); 1988 Oct; 91(14):525-9. PubMed ID: 3216742
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes.
    Balintescu A; Mårtensson J
    Crit Care Clin; 2019 Apr; 35(2):289-300. PubMed ID: 30784610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reliability of pre- and post-breakfast blood glucose as an index of glucose control in elderly diabetics].
    Ohba K; Haruyama M; Minami M; Nakano H; Yamashita N; Fuchigami M; Takao Y; Nozaki T; Shiga Y; Metori S
    Nihon Ronen Igakkai Zasshi; 1987 Nov; 24(6):532-7. PubMed ID: 3449653
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemoglobin A1 levels in diabetic patients: relation to metabolic control].
    Davidoff P; García de los Ríos M; Tapia JC; Saavedra I; Valdés E; Ruiz F
    Rev Med Chil; 1983 Feb; 111(2):124-8. PubMed ID: 6648086
    [No Abstract]   [Full Text] [Related]  

  • 8. Measuring What Matters in Diabetes.
    Rodriguez-Gutierrez R; McCoy RG
    JAMA; 2019 May; 321(19):1865-1866. PubMed ID: 30985865
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemoglobin A1 and hemoglobin A1c in elderly diabetics.
    Oimomi M; Matsumoto S; Hatanaka H; Ishikawa K; Kawasaki T; Kubota S; Yoshimura Y; Baba S
    Kobe J Med Sci; 1985 Apr; 31(2):95-101. PubMed ID: 4021433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glycosylated hemoglobin and diabetes. A determination of glycemic past with a future significance].
    Costa B
    Med Clin (Barc); 1991 Apr; 96(14):534-6. PubMed ID: 2051805
    [No Abstract]   [Full Text] [Related]  

  • 11. [More than diabetics?].
    Trivin F
    Ann Biol Clin (Paris); 1998; 56(4):385-6. PubMed ID: 9841575
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the clinical significance of glycosylated hemoglobin as an index for glycemic control in diabetic patients].
    Sasaki A; Matsumiya K; Arao M; Horiuchi N; Hasegawa K; Uehara M
    Rinsho Byori; 1986 Jul; 34(7):800-4. PubMed ID: 3761636
    [No Abstract]   [Full Text] [Related]  

  • 13. Global standardisation of haemoglobin A(1c) using metrological principles.
    John WG
    Clin Biochem; 2012 Sep; 45(13-14):1048-50. PubMed ID: 22874657
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glycosylated hemoglobin and diabetes mellitus. Clinical application?].
    Kjaergaard JJ; Madsen H; Mourits-Andersen T; Ditzel J
    Ugeskr Laeger; 1981 Dec; 143(50):3367-70. PubMed ID: 7336488
    [No Abstract]   [Full Text] [Related]  

  • 15. Q: Is hemoglobin A1c an accurate measure of glycemic control in all diabetic patients?
    Bazerbachi F; Nazarian S; Alraiyes AH; Alraies MC
    Cleve Clin J Med; 2014 Mar; 81(3):146-9. PubMed ID: 24591470
    [No Abstract]   [Full Text] [Related]  

  • 16. Should the recommendation of the American Association of Clinical Endocrinologists for a hemoglobin A1c target of 6.5% be modified? A critical reappraisal of recent studies of intensive glycemic control.
    Rodbard HW; Trence DL; Mechanick JI
    Endocr Pract; 2008 Sep; 14(6):791-5. PubMed ID: 18996803
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes mellitus: the role of the laboratory--an update.
    Khan SR
    J Pak Med Assoc; 2002 Dec; 52(12):569-75. PubMed ID: 12627907
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glycosylated serum proteins in diabetics].
    Balázsi I; Varsányi-Nagy M; Várnai Z; Karádi I; Rohla M
    Orv Hetil; 1983 Mar; 124(11):629-30. PubMed ID: 6843984
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of continuous insulin delivery systems in treatment of diabetes mellitus.
    Kitabchi AE; Fisher JN; Matteri R; Murphy MB
    Adv Intern Med; 1983; 28():449-90. PubMed ID: 6340430
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes and cystic fibrosis. Survey of glucose intolerance factors].
    Robert JJ; Grasset E; de Montalembert M; Deschamps I; Boitard C; Lenoir G
    Ann Pediatr (Paris); 1991 Dec; 38(10):657-60. PubMed ID: 1772204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.